Digitoxin increases sensitivity of glioma stem cells to TRAIL-mediated apoptosis
1School of Clinical Medicine, Tsinghua University, NO.1, Tsinghua Yuan, Handian District, Beijing, PR China.
Abstract:
Malignant glioma is one type of common malignancy in central nervous system (CNS) tumors which has a very bad influence on the survival quality of the patients. In this regard, lots of studies on improving the therapeutic effects of malignant glioma have been done continuously. This study takes glioma stem cells (GSCs) as the subject and focuses on the sensitization effect of digitoxin (DT) on the apoptosis mediated by TNF-related apoptosis-inducing ligand (TRAIL) to prove that the combination therapy of DT and TRAIL has a more active effect of inducing GSCs apoptosis. This study used cultured GSCs. Comparisons of single drug therapy and combination therapy indicated that DT had a synergistic action with TRAIL to produce a more active effect of inducing the apoptosis of GSCs. This effect was also shown in the changes of expressions of cell apoptosis pathway related protein markers tested by Western Blot method. In conclusion, DT had a sensitization effect on GSCs apoptosis mediated by TRAIL.
Insights
Digitoxin (DT) enhances TRAIL-induced apoptosis in glioma stem cells (GSCs). Combination therapy of DT and TRAIL shows synergistic effects, improving apoptosis induction for malignant glioma treatment.
Area of Science:
- Neuro-oncology
- Cancer biology
- Pharmacology
Background:
- Malignant glioma is a common central nervous system (CNS) tumor with poor patient prognosis.
- Glioma stem cells (GSCs) are crucial for tumor growth and therapeutic resistance.
- Developing effective therapies targeting GSCs is essential for improving patient outcomes.
Purpose of the Study:
- To investigate the sensitizing effect of digitoxin (DT) on TNF-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in GSCs.
- To evaluate the efficacy of combination therapy using DT and TRAIL in inducing GSCs apoptosis.
Main Methods:
- Cultured GSCs were used as the experimental model.
- Comparative analysis of single-drug therapy versus combination therapy (DT + TRAIL).
- Western Blot analysis to assess changes in apoptosis-related protein markers.
Main Results:
- DT demonstrated a synergistic action with TRAIL, significantly enhancing GSCs apoptosis.
- Combination therapy showed a more potent apoptotic effect compared to single-drug treatments.
- Western Blot confirmed alterations in apoptosis pathway protein expressions.
Conclusions:
- Digitoxin (DT) sensitizes glioma stem cells (GSCs) to TRAIL-mediated apoptosis.
- The combination of DT and TRAIL offers a promising therapeutic strategy for malignant glioma.
- Targeting GSCs apoptosis with DT and TRAIL warrants further investigation for CNS tumor treatment.
